Genor Biopharma Holdings Limited's market cap is currently €214.44M. The company's EPS TTM is €-0.012304096; its P/E ratio is 75.56; Genor Biopharma Holdings Limited is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in CNY
Genor Biopharma Holdings Limited Earnings and Revenue History
